Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sleep-Related Urologic Dysfunction.
Silvestri R. Silvestri R. Sleep Med Clin. 2024 Mar;19(1):169-176. doi: 10.1016/j.jsmc.2023.10.009. Epub 2023 Nov 13. Sleep Med Clin. 2024. PMID: 38368063 Review.
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology.
Corrado A, Aceto R, Miglietta S, Silvestri R, Dell'Anno I, Lepori I, Ricci B, Romei C, Giovannoni R, Poliseno L, Evangelista M, Vitiello M, Cipollini M, Elisei R, Landi S, Gemignani F. Corrado A, et al. Among authors: silvestri r. 3 Biotech. 2024 Feb;14(2):45. doi: 10.1007/s13205-023-03878-4. Epub 2024 Jan 19. 3 Biotech. 2024. PMID: 38261961 Free PMC article.
Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition.
Ćurčić V, Olszewski M, Maciejewska N, Višnjevac A, Srdić-Rajić T, Dobričić V, García-Sosa AT, Kokanov SB, Araškov JB, Silvestri R, Schüle R, Jung M, Nikolić M, Filipović NR. Ćurčić V, et al. Among authors: silvestri r. Arch Pharm (Weinheim). 2024 Feb;357(2):e2300426. doi: 10.1002/ardp.202300426. Epub 2023 Nov 22. Arch Pharm (Weinheim). 2024. PMID: 37991233
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells.
Masci D, Puxeddu M, Di Magno L, D'Ambrosio M, Parisi A, Nalli M, Bai R, Coluccia A, Sciò P, Orlando V, D'Angelo S, Biagioni S, Urbani A, Hamel E, Nocentini A, Filiberti S, Turati M, Ronca R, Kopecka J, Riganti C, Fionda C, Bordone R, Della Rocca G, Canettieri G, Supuran CT, Silvestri R, La Regina G. Masci D, et al. Among authors: silvestri r. J Med Chem. 2023 Nov 9;66(21):14824-14842. doi: 10.1021/acs.jmedchem.3c01424. Epub 2023 Oct 30. J Med Chem. 2023. PMID: 37902628 Free PMC article.
Biological evaluation of [4-(4-aminophenyl)-1-(4-fluorophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models.
Mazzoccoli C, Crispo F, Laurenzana I, Pietrafesa M, Sisinni L, Lerose R, Telesca D, Milella MR, Liu T, Della Sala G, Sebastiani J, Silvestri R, La Regina G. Mazzoccoli C, et al. Among authors: silvestri r. Arch Pharm (Weinheim). 2023 Oct;356(10):e2300354. doi: 10.1002/ardp.202300354. Epub 2023 Aug 21. Arch Pharm (Weinheim). 2023. PMID: 37603378
319 results